Merit Medical Systems, Inc.  

(Public, NASDAQ:MMSI)   Watch this stock  
Find more results for Nolan E. Karras
23.44
-0.03 (-0.13%)
After Hours: 23.44 0.00 (0.00%)
Jul 29, 4:47PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 23.00 - 23.75
52 week 15.47 - 26.28
Open 23.40
Vol / Avg. 359,432.00/317,558.00
Mkt cap 1.05B
P/E 45.57
Div/yield     -
EPS 0.51
Shares 44.30M
Beta 0.82
Inst. own 91%
Oct 20, 2016
Q3 2016 Merit Medical Systems Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 27, 2016
Q2 2016 Merit Medical Systems Inc Earnings Call - Webcast
Jul 27, 2016
Q2 2016 Merit Medical Systems Inc Earnings Release
Jul 6, 2016
Merit Medical Systems Inc Conference Call to Discuss a Definitive Agreement to Acquire DFINE Inc
May 26, 2016
Merit Medical Systems Inc Annual Shareholders Meeting
May 23, 2016
Merit Medical Systems Inc at UBS Global Healthcare Conference
May 20, 2016
Merit Medical Systems Inc Annual Shareholders Meeting (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 4.83% 4.39%
Operating margin 7.67% 6.92%
EBITD margin - 13.83%
Return on average assets 3.61% 3.12%
Return on average equity 6.14% 5.28%
Employees 3,754 -
CDP Score - -

Address

1600 W Merit Pkwy
SOUTH JORDAN, UT 84095-2416
United States - Map
+1-801-2531600 (Phone)
+1-801-2531652 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Merit Medical Systems, Inc. is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its products are used in various clinical areas, such as diagnostic and interventional cardiology; interventional radiology; vascular, general and thoracic surgery; interventional pulmonology; interventional nephrology; oncology, and pain management.

Officers and directors

Fred P. Lampropoulos Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bernard Birkett Chief Financial Officer
Bio & Compensation  - Reuters
Ronald A. Frost Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
David M. Liu Director
Bio & Compensation  - Reuters
Kent W. Stanger Director
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
A. Scott Anderson Independent Director
Age: 68
Bio & Compensation  - Reuters
Richard W. Edelman Independent Director
Age: 74
Bio & Compensation  - Reuters
Nolan E. Karras Independent Director
Age: 70
Bio & Compensation  - Reuters